Circulating tumour cells as surrogate biomarkers in castration-resistant prostate cancer trials

Eur Urol. 2011 Nov;60(5):905-7. doi: 10.1016/j.eururo.2011.08.024. Epub 2011 Aug 19.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Abiraterone Acetate
  • Androstadienes / therapeutic use*
  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Biomarkers, Tumor / genetics*
  • Enzyme Inhibitors / therapeutic use*
  • Humans
  • Male
  • Neoplastic Cells, Circulating / metabolism*
  • Oncogene Proteins, Fusion / genetics*
  • Orchiectomy*
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / genetics*
  • Steroid 17-alpha-Hydroxylase / antagonists & inhibitors*

Substances

  • Androstadienes
  • Antineoplastic Agents, Hormonal
  • Biomarkers, Tumor
  • Enzyme Inhibitors
  • Oncogene Proteins, Fusion
  • TMPRSS2-ERG fusion protein, human
  • CYP17A1 protein, human
  • Steroid 17-alpha-Hydroxylase
  • Abiraterone Acetate